OPRX OptimizeRx Corp

OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach

OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach

Change Healthcare Users Gain Access to Prescription Savings and Critical Treatment Information Directly at the Point-of-Care

ROCHESTER, Mich., July 27, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers and patients, has completed the latest expansion of its digital health communication network in collaboration with Change Healthcare (Nasdaq: CHNG).

Change Healthcare's Intelligent Healthcare Network™ is the broadest and deepest in the industry, driving 14 billion transactions each year, delivering $150 billion in payments, and providing unparalleled insights for the company’s data solutions business. The platform enables end-to-end workflows––from eligibility through payments––and supports a broad set of data and analytics offerings that create value for Change Healthcare customers.

The integration of the two companies’ digital health platforms strengthens their mutual efforts to improve transparency and patient experience in healthcare. The connected platforms enable certain providers in the Change Healthcare network to digitally receive important information from the life sciences industry via OptimizeRx.

These providers have gained real-time access to critical drug savings, treatment information, refill reminders, sponsored patient engagement programs and more, directly within their daily electronic workflow and while consulting with their patients. Access to these valuable resources at the point-of-care helps to support more productive patient-provider communication and clinical decisions, and ultimately a better experience for the patient. 

“Enabling providers to deliver patient-centered care is at the core of what we do,” said Ian Ellis, vice president and general manager of clinical exchange for Change Healthcare. “Our collaboration with OptimizeRx demonstrates our commitment to helping providers improve the patient experience through enhanced capabilities for our e-prescribing solution.”

Miriam Paramore, president of OptimizeRx, commented: “Transparency in healthcare, supported by the right digital communication tools, is key to creating better health outcomes. Our collaboration with Change Healthcare expands our ability to reach providers within their daily digital workflow. We anticipate our connection will have a significant positive impact on the health of millions of patients nationwide.”

For more information on OptimizeRx, its products or other news, visit .

About OptimizeRx

OptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRx’s network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a provider’s workflow through leading electronic health platforms. OptimizeRx’s fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.

For more information, follow the company on ,  or visit 

Important Cautions Regarding Forward Looking Statements

This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. 

Intelligent Healthcare Network™ is a trademark of Change Healthcare, Inc.

OptimizeRx Contact 

Doug Baker, CFO

Tel (248) 651-6568 (x807)

 

Media Relations Contact 

Maira Alejandra, Media Relations Manager

Tel (754) 245-7070

Investor Relations Contact 

Ron Both, CMA 

Tel (949) 432-7557 

EN
27/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OptimizeRx Corp

 PRESS RELEASE

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fi...

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HC...

 PRESS RELEASE

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) R...

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2025. As a company focused on optimizing meaningful engagement opportunities at critical junctures of the healthcare journey, we remain dedicated to aligning our mission with our responsibilities as a corporate ci...

 PRESS RELEASE

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, a...

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Monday, May 12, 2025, at 4:30 p.m. Eastern Time to discuss its results for the first quarter period ended March 31, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, follow...

 PRESS RELEASE

OptimizeRx Corporation Announces Plan for Additional Board of Director...

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that, as part of OptimizeRx’s ongoing process to refresh and expand its board of directors (the “Board”), it intends to appoint a new independent director to its Board of Directors during the second half of this year.  With the appointment of a new independent ...

 PRESS RELEASE

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial ...

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch